RETRACTED: Efficacy and safety of omega-3 for treatment of early-stage Peyronie's disease: A prospective, randomized, double-blind placebo-controlled study

J Sex Med. 2009 Jun;6(6):1743-1754. doi: 10.1111/j.1743-6109.2009.01235.x. Epub 2009 Apr 23.

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief. Following the retraction of Dr. Safarinejad's work by other journals, The Journal of Sexual Medicine has undertaken an extensive re-review of all papers Dr. Safarinejad published with the journal. Following an intensive re-evaluation and close scrutiny of the manuscripts, our expert reviewers raised multiple concerning questions about the methodology, results, and statistical interpretation as presented in this article. Dr. Safarinejad was contacted to provide his original data and offer explanations to address the concerns expressed by the reviewers. Dr Safarinejad chose not to respond. Consequently, we can no longer verify the results or methods as presented and therefore retract the article.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Double-Blind Method
  • Eicosapentaenoic Acid / adverse effects
  • Eicosapentaenoic Acid / therapeutic use*
  • Erectile Dysfunction / diagnosis
  • Erectile Dysfunction / epidemiology
  • Humans
  • Male
  • Middle Aged
  • Penile Induration / drug therapy*
  • Penile Induration / epidemiology
  • Prospective Studies
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Eicosapentaenoic Acid